Skip to main content
All lobbying filings

Leavitt Partners, LLC

Leavitt Partners, LLC filed a Q3 report for Baxter Healthcare on October 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Baxter Healthcare · pharmaceutical and patient safety issues

As filed: LEAVITT PARTNERS, LLC for BAXTER HEALTHCARE.

All filings by Leavitt Partners, LLC · Everything Baxter Healthcare has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
Illinois

Official filing document

 Lobbyists on this filing 3
  • ROBERT CLAYTON ALSPACH
    Previously held: Chief Health Counsel for Chairman - House Energy and Commerce Committee (E&C); Counsel - E&C; Clerk - E&C; Paid Intern - E&C
  • MELISSA PFAFF
    Previously held: Senate HELP: Senior Health Policy Advisor-Ranking Member (RM); Senior Policy Advisor-Chair; Health Policy Advisor-Chair; Prof Staff Member-Chair; Prof Staff Member-RM; Prof Staff Member RM-Senate Budget; Leg Corres-Senate; Staff Assistant-Senate
  • MICHELLE ADAMS New on this filing
    Previously held: Senior Policy Advisor, CBER; Senior Advisor Office of Commissioner FDA; Acting Director/Senior Specialist, Intergovernmental Affairs FDA; Congress Affairs Specialist FDA; Senior Health Leg Assistant Senate; Leg Director House; Leg Assistant House

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Pharmaceutical, medical products, and patient safety issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem